These are preliminary reports that have not been peer-reviewed. They should not be regarded as conclusive, guide clinical practice/health-related behavior, or be reported in news media as established information. For more information, please see our FAQs.
3 files

An Integrated Console for Capsule-Based, Fully Automated Organic Synthesis

submitted on 22.03.2019, 18:17 and posted on 25.03.2019, 16:35 by Tuo Jiang, Samuele Bordi, Angus E. McMillan, Kuang-Yen Chen, Fumito Saito, Paula Nichols, Benedikt Wanner, Jeffrey Bode
The current laboratory-based practice of organic synthesis renders automation difficult, suffers from safety and environmental hazards, and hampers the implementation of artificial intelligence guided drug discovery. Using a combination of innovative reagent design, hardware engineering, and a simple operating system we provide an instrument capable of executing complex organic reactions with prepacked capsules in a fully automated fashion. The machine conducts coupling reactions and delivers the purified products with minimal user involvement. Two of the most desirable reaction classes – the synthesis of saturated N-heterocycles and reductive amination – were implemented, along with multi-step sequences that provide drug-like organic molecules in a fully automated manner. We envision that this system will serve as a console for developers to provide synthetic methods as integrated, user-friendly packages for conducting organic synthesis in a safe and convenient fashion.



ERC-2015-PoC - Hetspresso

ETH Pioneer Fellowship

Innosuisse 27406.1 PFLS-LS


Email Address of Submitting Author


ETH Zurich



ORCID For Submitting Author


Declaration of Conflict of Interest

B.M.W., P.L.N, T.J, and J.W.B. are co-founders and shareholders of Synple Chem AG. ETH Zürich has filed a patent related to the technology; B.M.W.; P.L.N.; K.Y.C. and J.W.B. are listed as inventors.